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INTRODUCTIONS
Obstructive sleep apnea syndrome (OSAS) is a common chronic 
disease that requires long-term treatment and follow-up (1). The 
estimated prevalence of OSAS in middle-aged Koreans is 4.5% 
in males and 3.2% in females (2).
  Treatment for OSAS consists of medical, behavioral and surgi-
cal therapy (1, 3). Medical therapy includes continuous positive 
airway pressure (CPAP) and oral appliances, and behavioral 
therapy consists of weight loss and positional therapy (1, 4-8). In 
1981, Sullivan et al. (4) first introduced nasal CPAP, working as 
a pneumatic splint to prevent upper airway collapse, for OSAS 
treatment. CPAP is routinely recommended for treatment in pa-
tients with moderate to severe OSAS and optionally indicated 
for the treatment of patients with mild OSAS (9). After CPAP 
treatment, benefits in patients with OSAS include improvement 
of self-reported daytime sleepiness and quality of life (10, 11). 
  An optimal CPAP level is important. A lower than optimal 
CPAP level may result in insufficient treatment effects and/or 
Objectives. The aim of this study was to investigate optimal continuous positive airway pressure (CPAP) level, to examine 
the factors affecting optimal CPAP level, and to develop a predictive equation for optimal CPAP level in Korean pa-
tients with obstructive sleep apnea syndrome (OSAS).
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unintentional mask removal, while a higher than optimal CPAP 
level may induce pressure intolerance and/or mouth dryness 
(12). Three titration methods are used to establish an optimal 
level: full-night, split-night, and titration using auto-titrating pos-
itive airway pressure (APAP). Of these, full-night, attended titra-
tion with polysomnography (PSG) is the gold standard to deter-
mine an optimal CPAP level (1). Although full-night manual ti-
tration in a sleep laboratory is the preferred method, APAP titra-
tion may be performed to identify optimal CPAP level for pa-
tients with moderate to severe OSAS without congestive heart 
failure, chronic obstructive pulmonary disease, or hypoventila-
tion syndrome (13). 
  Various predictive equations for optimal CPAP level have 
been developed in several countries and for populations of dif-
ferent geographical origins (14-20). The optimal CPAP level de-
termined by a predictive equation may improve the success rate 
of manual titration and increase the convenience of treatments 
such as patient self-titration of CPAP or APAP (21-23). There-
fore, the objectives of the present study were: 1) to investigate 
mean optimal CPAP level according to the severity of OSAS; 2) 
to examine the factors which affect optimal CPAP level; and 3) 
ultimately to develop predictive equation for optimal CPAP lev-
el using variables which can be easily measured during the diag-
nostic process in Korean patients with OSAS.
MATERIALS AND METHODS
Subjects
Two hundred two Korean patients diagnosed with OSAS using 
the apnea-hypopnea index (AHI) in standard PSG ≥5 with 
signs and symptoms suspicious for OSAS, and who underwent a 
successful manual titration for CPAP treatment between April 
2002 and December 2004 were included in this study. The sub-
jects comprised 182 males and 20 females with mild (n=54), 
moderate (n=49), and severe (n=99) OSAS (Table 1). Mean age 
and body mass index (BMI, weight in kg divided by height in 
m
2) was 44.8±9.3 years and 27.6±3.4 kg/m
2, respectively. Se-
verity of OSAS was classified according to the degree of AHI. 
Mild, moderate, and severe OSAS for adults were defined as 5≤
AHI<15, 15≤AHI<30, AHI≥30, respectively (24). Neck cir-
cumference (cm) was measured at the level just below the most 
prominent portion of the thyroid cartilage (Adam’s apple). The 
study was reviewed and approved by the Institutional Review 
Board at Ansan Hospital, Korea University.
PSG and CPAP titration
All subjects underwent an overnight, in-laboratory attended 
PSG with an Alice 4 computerized polysomnographic system 
(Respironics, Atlanta, GA, USA). Sixteen channels were simul-
taneously used to document the following parameters: four 
channel electroencephalogram, electrooculogram, submental 
and leg electromyogram, electrocardiogram, airflow at the nose 
and mouth (thermistor, nasal pressure transducer), chest and ab-
dominal respiratory movement, oxygen saturation (pulse oxime-
try), snoring microphone, and body position sensor. A sleep 
technician observed the behavior of the subjects and confirmed 
their sleep positions using an infrared camera inside the room.
To determine optimal pressure level for CPAP treatment, full-
night, manual titration with the same montage PSG was per-
formed. The optimal pressure level was defined as the lowest ef-
fective pressure that controlled most respiratory disturbances in-
Table 1. Anthropometric and polysomonographic variables according to the severity of OSAS
Mild (n=54) Moderate (n=49) Severe (n=99) Total (n=202)
Anthropometric variables
Age (years) 44.8±10.6  46.8±9.4  43.8±8.5  44.8±9.3
Sex (male:female) 46:8  43:6  93:6  182:20
Neck circumference (cm) 37.6±4.1  37.7±5.4  39.9±5.0  38.7±4.9 
Body mass index (kg/m
2) 25.8±3.0  26.9±2.8  28.9±3.4  27.6±3.4 
Polysomnographic variables
TST (minutes) 373.3±62.0  368.9±63.0  389.3±60.2  380.1±61.7 
Sleep efficiency (%) 83.7±9.0  81.6±10.5  82.8±10.8  82.8±10.3 
Arousal index (events/hour of TST) 22.2±7.8  28.7±7.8  57.8±17.1  41.2±21.1 
Sleep–stage duration (% of TST)
Stage N1 14.1±8.7  17.0±9.5  27.9±18.3  21.6±15.6 
Stage N2 59.1±9.1  58.2±10.6  51.9±17.7  55.4±14.6 
Stage N3 (slow wave sleep) 6.9±6.4  5.7±5.0  2.2±4.0  4.4±5.4 
Stage R (REM sleep) 19.9±5.4  19.1±6.1  17.8±6.4  18.7±6.1 
AHI (events/hour of TST) 9.3±2.7  21.8±4.1  58.9±15.9  36.6±25.1
Snoring (%) 27.7±22.4  23.5±19.0  18.4±14.9  22.1±18.5 
Minimal SaO2 (%) 83.6±5.3  80.8±5.1  72.1±11.3  77.3±10.1 
Data are presented as mean±SD.
OSAS: obstructive sleep apnea syndrome; TST: total sleep time; REM: rapid eye movement; AHI: apnea-hypopnea index. Choi JH et al.: Optimal CPAP Level in Korean OSAS Patients    209
cluding apnea, hypopnea, and snoring in all body positions and 
in all stages, especially in the supine position during rapid eye 
movement (REM) sleep.
  All the sleep studies were manually interpreted by a sleep 
technician according to the standard sleep stage and arousal cri-
teria (25, 26). Apnea was defined as absence of airflow for a pe-
riod lasting at least 10 seconds and hypopnea was defined as at 
least a 30% reduction in airflow associated with decrease in ox-
ygen saturation of 4% or more. The apnea index was defined as 
the number of apneic episodes per hour of total sleep time, and 
the AHI was defined as the number of episodes of apnea and 
hypopnea per hour of total sleep time. Arousal index was de-
fined as the number of arousals per hour of total sleep time.
Statistical analysis
All data are presented as the mean±standard deviation for con-
tinuous variables, and as frequencies (percent) for categorical 
variables. Pearson’s correlation coefficients were used to analyze 
relationships between optimal CPAP level and baseline data in-
cluding anthropometric and polysomnographic variables. Step-
wise multiple linear regression analysis was used to select inde-
pendent predictive variables and to develop a predictive equa-
tion for optimal CPAP level. Statistical analysis was performed 
using SPSS ver. 10.0 (SPSS Inc., Chicago, IL, USA), and P<0.05 
was considered statistically significant.
RESULTS
The mean optimal pressure level for CPAP treatment according 
to the severity of OSAS is shown in Table 2. The mean optimal 
pressure level in the 202 OSAS patients was 7.8±2.3 cm H2O. 
The mean optimal pressure levels in the mild, moderate, and se-
vere OSAS groups was 6.0±1.3, 7.4±1.9, and 9.1±2.1 cm 
H2O, respectively.
  Correlations between optimal pressure level for CPAP treat-
ment and baseline variables including demographic and polyso-
monographic data in the 202 patients are presented in Table 3. 
AHI (r=0.595, P<0.001), arousal index (r=0.542, P<0.001), 
minimal SaO2 (r=-0.502, P<0.001), BMI (r=0.494, P<0.001), 
neck circumference (r=0.265, P<0.001), and age (r=-0.164, 
P=0.019) were significantly correlated with optimal pressure 
level.
  Of the anthropometric and polysomnographic variables, step-
wise multiple linear regression analysis identified BMI and AHI 
as independent predictive variables associated with the optimal 
pressure level. The best predictive equation by stepwise regres-
sion analysis was: 
  Optimal CPAP level (cm H2O)=0.681+(0.205×BMI)+
(0.040×AHI)
  Forty-two percent of the variance in the optimal CPAP level 
was explained by this equation (R
2=0.42, P<0.001).
DISCUSSION
The ultimate objective of this study, to develop a predictive 
equation for optimal CPAP level using easily measured variables 
during diagnostic evaluation in Korean OSAS patients, was ac-
complished.
  Lin et al. (17) constructed a predictive model for optimal 
CPAP level in 121 adult Taiwanese patients with OSAS and de-
veloped the following equation: Optimal CPAP level (cm 
H2O)=0.52+(0.174×BMI)+(0.042×AHI). Their predictive 
model is in close agreement with our equation, in that BMI and 
AHI were the two most important independent predictors of 
optimal CPAP level. Akahoshi et al. (20) produced a predictive 
equation derived from anthropometric, polysomnographic, and 
cephalometric data in 170 Japanese patients with OSAS. In the 
study, stepwise multiple regression analysis selected BMeH (the 
angle between a line from point <B> to menton <Me> and a 
line from Me to the hyoid bone <H>), BMI, AHI, and mean 
SaO2 as independent predictors of effective pressure. The predic-
tive equation was: Optimal CPAP level (cm H2O)=27.78+
(0.041×BMeH)+(0.141×BMI)+(0.040×AHI)-(0.312×mean 
SaO2). Although optimal pressure was more accurately predicted 
by combining cephalometric data such as BMeH with BMI, AHI, 
and mean SaO2, cephalometric analysis may decrease the clini-
Table 2. Mean optimal CPAP level according to the severity of OSAS
Mean optimal CPAP (range)
Mild (n=54) 6.0±1.3 (4–9)
Moderate (n=49) 7.4±1.9 (4–13)
Severe (n=99) 9.1±2.1 (5–15)
Total (n=202) 7.8±2.3 (4–15)
Data are presented as mean±SD.
CPAP: continuous positive airway pressure; OSAS: obstructive sleep 
apnea syndrome.
Table 3. Relationship between optimal CPAP level and baseline vari-







Age (years) 44.8±9.3  -0.164  0.019 
Neck circumference (cm) 38.7±4.9  0.265  <0.001 
Body mass index (kg/m
2) 27.6±3.4  0.494  <0.001 
Polysomnographic variables
Arousal index 
  (events/hour of TST)
41.2±21.1  0.542  <0.001 
AHI (events/hour of TST) 36.6±25.1  0.595  <0.001 
Snoring (%) 22.1±18.5  -0.026  NS 
Minimal SaO2 (%) 77.3±10.1  -0.502  <0.001 
Data are presented as mean±SD.
CPAP: continuous positive airway pressure; OSAS: obstructive sleep 
apnea syndrome; TST: total sleep time; AHI: apnea-hypopnea index; 
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cal usefulness of this equation.
  Rowley et al. (21) investigated the effect of predictive equa-
tions on the success rate of manual titration for CPAP treatment. 
They found that manual titration using predictive equation mod-
estly increases the success rate of CPAP titration. The success 
rate of titration studies for which the AHI at the final level tested 
≤50% of baseline and ≤10 events/hour increased from 50% 
to 68% (P<0.001). It is thought that the predictive equation 
worked by reducing complex steps and time-consuming efforts 
to determine effective pressure levels. Fitzpatrick et al. (22) 
compared results between in-laboratory manual titration and 
home self-titration of CPAP for OSAS in a randomized, single-
blind, two-period crossover study. Patient self-titration of CPAP 
was performed based on the optimal CPAP level by the predic-
tive equation. The authors demonstrated that home self-titration 
of CPAP using a predictive equation is as effective as in-labora-
tory manual titration during full-night PSG, with similar CPAP 
compliance, subjective, and objective outcomes.
  Predictive equations for optimal CPAP level may be required 
for the following objectives: 1) to improve the success rate of 
full-night, in-laboratory manual titration, because the starting 
pressure by predictive equation would be closer to the optimal 
CPAP level (e.g., simplifying the titration process as decreasing 
numerous pressure changes and time consumption to obtain an 
optimal pressure level); 2) to increase the convenience and ef-
fectiveness of home patient management (e.g., home self-titra-
tion of CPAP or APAP); 3) to be substituted for manual titration 
in several conditions in which manual titration in a sleep labora-
tory is not possible (e.g., immobility, safety, and critical illness); 
and 4) as an alternative to manual titration in cases in which ti-
tration using a predictive equation would be preferable to man-
ual titration (e.g., high cost, time consumption, and long waiting 
list).
  The strength of the current study is that the study sample was 
large and included patients with mild OSAS. In two previous 
East Asian studies, the study samples were 121 patients with 
moderate to severe OSAS and 170 patients with an AHI of 
more than 20 (17, 20). CPAP is optionally indicated for the 
treatment of patients with mild OSAS. We believe that a better 
predictive equation may be developed for the large number of 
patients with OSAS, including those with mild OSAS.
  There were several limitations in the present study. This study 
did not include a validation or application of the presently de-
veloped equation to another group of Korean OSAS patients. 
Although cephalometric data may influence optimal pressure 
level, craniofacial abnormalities were not considered in the de-
velopment of this predictive equation because the required 
cephalometric analysis may have diminished the clinical utility 
of this equation.
  In conclusion, a predictive equation for optimal CPAP level 
was developed using AHI and BMI, which can be easily mea-
sured during diagnostic work-up. We expect that this predictive 
equation for optimal CPAP level will be helpful for designing 
CPAP treatment in Korean patients with OSAS.
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